Litcius/Paper detail

Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone

Scott D. Berkowitz, Rupert Bauersachs, Michael Szarek, Mark R. Nehler, E. Sebastian Debus, Manesh R. Patel, Sonia S. Anand, Warren H. Capell, Connie N. Hess, Judith Hsia, Nicholas J. Leeper, David Brasil, Lajos Mátyás, Rafael Díaz, Marianne Brodmann, Eva Muehlhofer, Lloyd Haskell, Marc P. Bonaca

2022Journal of Thrombosis and Haemostasis16 citationsDOIOpen Access PDF

Topics & Concepts

MedicineRivaroxabanAspirinInternal medicineHazard ratioPost-thrombotic syndromeCardiologyVascular diseaseRevascularizationThrombosisVenous thrombosisSurgeryWarfarinConfidence intervalMyocardial infarctionAtrial fibrillationPeripheral Artery Disease ManagementDiagnosis and Treatment of Venous DiseasesAntiplatelet Therapy and Cardiovascular Diseases
Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone | Litcius